Form 4: Monster Beverage Exec Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report 17 November 2025 5:48 PM

Monster Beverage Corp's President of EMEA & OSP, Guy Carling, exercised stock options and sold a significant portion of his common stock holdings in a pre-planned transaction.

Summary

Guy Carling, President of EMEA & OSP at Monster Beverage Corp (MNST), executed a series of transactions on November 13, 2025.
Carling acquired a total of 38,438 shares of common stock through the exercise of employee stock options at various prices: 6 shares at $25.75, 9,000 shares at $44.47, 16,100 shares at $36.62, and 13,332 shares at $50.82.
Concurrently, Carling disposed of 38,438 shares of common stock at a weighted average sale price of $71.33, with individual trades ranging from $70.09 to $71.70.
These transactions were made pursuant to a Rule 10b5-1(c) plan.
Following these transactions, Carling's direct beneficial ownership of common stock is 21,993 shares.
Carling continues to hold a substantial number of unexercised employee stock options and unvested Restricted Stock Units (RSUs) with various vesting schedules extending through March 2029 and expiration dates through March 2035.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the executive is monetizing vested options, which is a positive for personal finance, the sale of a significant block of shares, even if pre-planned, can sometimes be interpreted cautiously by the market. However, the executive retains substantial equity and derivative holdings, mitigating a strong negative signal.

Positives

The executive monetized vested stock options, indicating a realization of value from long-term incentives.
The transactions were executed under a Rule 10b5-1(c) plan, suggesting a pre-scheduled sale rather than an immediate reaction to new information.

Negatives

A significant sale of 38,438 shares by a high-ranking executive could be perceived negatively by some investors, even if it's part of a pre-planned strategy.

Risks

The market's perception of insider selling, even when pre-planned, can sometimes lead to short-term negative sentiment or downward pressure on the stock price.
Future stock price volatility could impact the value of the remaining unexercised options and unvested restricted stock units.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic outlook. It solely reports insider trading activities.

Industry Context

Insider transactions, particularly sales, are routinely monitored by investors as they can sometimes signal management's perception of future company performance or valuation. However, sales made under Rule 10b5-1 plans are generally viewed as less indicative of a change in sentiment, as they are pre-scheduled and often for personal financial planning or diversification.

Stakeholder Impact

Shareholders may react to the insider sale, potentially influencing short-term stock price movements.
The executive's personal financial planning is advanced through the monetization of vested equity.

Next Steps

Monitoring of future vesting dates for remaining employee stock options and restricted stock units held by the executive.
Observation of any subsequent insider transactions by this or other executives.

Key Dates

Date	Description
11/13/2025	Date of all reported stock option exercises and common stock sale transactions.
03/12/2026	Vesting date for remaining options (9,000 shares) and restricted stock units (1,680 units).
03/14/2026	Vesting date for various tranches of options (11,500, 4,000, 13,332, 2,700 shares) and restricted stock units (3,400, 1,360, 900, 7,000 units).
03/14/2027	Vesting date for various tranches of options (13,800, 5,000, 3,600 shares) and restricted stock units (4,080, 1,700, 1,200 units).
03/14/2028	Vesting date for various tranches of options (6,000, 4,500 shares) and restricted stock units (2,040, 1,500 units).
06/01/2028	Expiration date for employee stock options with an exercise price of $25.75.
03/14/2029	Vesting date for various tranches of options (5,400 shares) and restricted stock units (1,800 units).
03/12/2031	Expiration date for employee stock options with an exercise price of $44.47.
03/14/2032	Expiration date for employee stock options with an exercise price of $36.62.
03/14/2033	Expiration date for employee stock options with an exercise price of $50.82.
03/14/2034	Expiration date for employee stock options with an exercise price of $60.30.
03/14/2035	Expiration date for employee stock options with an exercise price of $55.09.
11/17/2025	Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

The filing reports a pre-planned insider transaction where an executive exercised options and immediately sold the resulting shares. While the sale of a large block of shares might typically raise concerns, the fact that it was executed under a Rule 10b5-1 plan suggests it's for personal financial management rather than a reaction to new, negative company-specific information. The executive still holds a significant number of direct shares and substantial unvested equity, indicating continued alignment with shareholder interests. Therefore, this single transaction does not warrant a change in investment thesis, leading to a 'hold' recommendation.

Keywords

Monster Beverage, MNST, Insider Trading, Form 4, Stock Options, Executive Compensation, Rule 10b5-1, Share Sale, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.